European Journal of Heart Failure

DECEMBER 7, 2023

Abstract Background and Aims Patients who experience hospitalizations due to heart failure (HF) face a significant risk of readmission and mortality. Methods We studied all adults admitted for a first HF hospitalization from 2016 to 2020 in France's Grand Est region. Results Among 67 476 admitted patients (mean age 80.3 ± 11.3 years,

Heart Failure 40

Heart Failure Hospital Outpatient Article 40

Cardiology Update

MARCH 17, 2024

Data were prospectively gathered from individuals aged 1 to under 18 years participating in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis long-term registry spanning from June 2014 to December 2016. Outcomes: Over a median follow-up of 12.5 months (IQR: 11.3–15.3),

Cardiomyopathy 119

Cardiomyopathy Pediatrics Heart Failure Research 119

Frontiers in Cardiovascular Medicine

FEBRUARY 14, 2024

Methods Using the Korean National Health Insurance Service database, we included patients aged ≥75 years with new-onset AF from January 2009 to December 2016 ( n  = 41,315). Group 4 was associated with the lowest risk of all-cause death (aHR: 0.680, 95% CI: 0.613–0.754) and the composite outcome (aHR: 0.708, 95% CI: 0.649–0.772).

Atrial Fibrillation 72

Atrial Fibrillation Stroke Strokes Heart Failure 72

Stroke Journal

FEBRUARY 1, 2024

Annual follow-up interviews were conducted from inception until 2016 to determine outcomes of interest. Hospital records were reviewed and incident MACE, defined as the composite of incident stroke, myocardial infarction, or heart failure, was adjudicated using standard criteria. P<0.001), physical activity (82.1

Myocardial Infarction 40

Myocardial Infarction Blood Pressure Outcomes Diet 40

European Journal of Heart Failure

NOVEMBER 3, 2023

Among 475 patients with cardiac sarcoidosis, 119 (25.1%) were isolated cardiac sarcoidosis (iCS) based on the 2016 Japanese Circulation Society criteria. iCS was diagnosed according to the 2016 Japanese Circulation Society (JCS) guidelines. months, 141 primary outcomes (29.7%) occurred. During a median follow-up of 42.3

Atrial Fibrillation 40

Atrial Fibrillation Heart Failure Tachycardia Arrhythmia 40

Heart BMJ

JUNE 25, 2024

The primary outcome was the first occurrence of major cardiovascular events defined as a composite of hospitalisation for acute coronary syndrome (non-fatal myocardial infarction and unstable angina), fatal myocardial infarction, non-fatal and fatal stroke, sudden death and heart failure. years (interquartile interval 4.4–4.9).

Cardiovascular Disease 59

Cardiovascular Disease Myocardial Infarction Pharmacology Angina 59

Journal of Cardiovascular Electrophysiology

FEBRUARY 13, 2024

Abstract Introduction Clinical outcomes of long-term ventricular septal pacing (VSP) without His-Purkinje capture remain unknown. This study evaluated the differences in clinical outcomes between conduction system pacing (CSP), VSP, and right ventricular pacing (RVP). Results Among 1016 patients (age 73.9 ± 11.2

Bradycardia 40

Bradycardia Physiology Pacemaker Heart Failure 40

Cardiometabolic Health Congress

JULY 25, 2023

There are significant data that show that if you have obesity, you have a high risk of developing coronary heart disease, heart failure, type 2 diabetes (T2D) or risk factors such as hypertension and dyslipidemia. [1] Is the obesity paradox a real phenomenon?

Obesity 52

Obesity BMI Heart Failure Cardiovascular Disease 52

Dr. S. Venkatesan MD

FEBRUARY 20, 2024

SCD is the leading cause of mortality in heart failure. N Engl J Med 2016; 375:1221-1230) Why ICD doesn’t work well in NDCM ? Bardy GH, Lee KL, Mark DB, Poole JE, Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. 2016 Sep 29;375(13):1221-30. N Engl J Med. 2005 Jan 20;352(3):225-37.

Heart Failure 52

Heart Failure Defibrillator Sudden Cardiac Death Cardiomyopathy 52

DAIC

JULY 24, 2024

The collaboration, according to a written statement issued by the company, aims to address challenges in capturing and analyzing cardiac signals to help physicians enhance patient outcomes for atrial fibrillation procedures. 1 Approximately 33 million patients worldwide are living with AFib.

Atrial Fibrillation 105

Atrial Fibrillation AFIB Ablation Technology 105

Circulation

JANUARY 23, 2024

BACKGROUND:Guideline-directed medical therapies (GDMTs) are the mainstay of treatment for heart failure with reduced ejection fraction (HFrEF), but they are underused. The primary outcome was the use of optimal GDMT within 12 months of HFrEF diagnosis.

Heart Failure 45

Heart Failure Medicare Circulation Outcomes 45

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Published Research kschukar Thu, 04/20/2023 - 11:12 Recently published (2016 – present) manuscripts utilizing STS data: Adult Cardiac Surgery, General Thoracic Surgery, Congenital Heart Surgery, and Intermacs/Pedimacs.

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Published Research kschukar Thu, 04/20/2023 - 11:12 Recently published (2016 – present) manuscripts utilizing STS data: Adult Cardiac Surgery, General Thoracic Surgery, Congenital Heart Surgery, and Intermacs/Pedimacs.

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Dr. Smith's ECG Blog

APRIL 8, 2015

Cardiac Syncope ("True Syncope") Independent Predictors of Adverse Outcomes condensed from multiple studies 1. History of Cardiovascular disease (all studies): Especially any history of heart failure or structural cardiac disease, including valvular 4. Abnormal ECG – looks for cardiac syncope. Syncope with Exertion (EGSYS) 7.

Arrhythmia 52

Arrhythmia Outcomes Risk Factors Chest Pain 52